Parkinson'
Conditions
Interventions
Comparison between medication and non-medication in patients suffering from Parkinson'
s disease
Guiding posture
Sponsors
National Institutes for Quantum Science and Technology Institute for Quantum Medical Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient group 1. Patients who meet the MDS criteria for Parkinson's disease Healthy control 1. A person who has the ability to provide informed consent 2. A person who matches the age with patient as possible
Exclusion criteria
Exclusion criteria: Patient group 1. A patient who cannot stand for 10min 2. A patient over Hoehn & Yahr Stage three 3. A patient with severe cognitive decline 4. A patient who has had drug abuse or substance dependence during the past year 5. A patient who overtly has had a brain disease (ex. cerebral infarction) 6. A patient who has serious coexisting illness (cardiac insufficiency, renal insufficiency, liver insufficiency, hemorrhagic peptic ulcer, intestinal obstruction, uncontrolled angle-closure glaucoma, cancer) 7. A patient who is pregnant or potentially pregnant 8. A patient who has a pacemaker, metal, or tattoo on his/her body 9. A patient with claustrophobia 10. A patient who is completely blind. 11. A participant who is regarded as ineligible for participation by a researcher /doctor Healthy control 1. A person who has had psychiatric disorders 2. A person who has had Parkinson's disease or other serious illness 3. A person who is pregnant or potentially pregnant 4. A person who has a pacemaker or metal on his/her body 5. A person who has tattoo on his/her body 6. A person with claustrophobia 7. A person who is completely blind. 8. A person who is regarded as ineligible for participation because of his/her disobedience or lack of understanding by a researcher /doctor 9. A person who is regarded as ineligible for participation by a researcher /doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlations among the degree of changing posture and MRI data. | — |
Secondary
| Measure | Time frame |
|---|---|
| EEG, performance in cognitive tasks | — |
Countries
Japan
Contacts
Public ContactKentaro Tamaki
Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Advanced Neuroimaging Center
Outcome results
None listed